tirzepatide chemical structure Tirzepatide | CAS#2023788-19-2 | GIP/GLP-1

In the STEP trials, semaglutide exhibited superiority in promoting weight reduction, making it a beacon of hope for individuals with obesity and type 2 diabetes seeking comprehensive improvements in health

J Diabetes Sci Technol 17(5):12261242

Certain medical conditions If you have certain health conditions, you should not take Wegovy

Stopping the medication may increase the risk of regaining the weight

Roles of Nicotinamide NMethyltransferase in Obesity and Type 2 Diabetes

Se necesitarn ensayos de resultados ms grandes y prolongados para responder a esa pregunta, apunta Naveed Sattar, catedrtico de Medicina Cardiometablica y Consultor Honorario de la Universidad de Glasgow (Reino Unido), tambin a Science Media Centre Reino Unido